Portal Pressure Predicts Outcome and Safety of Antiviral Therapy in Cirrhotic Patients With Hepatitis C Virus Infection

Thomas Reiberger(ERN GUARD-Heart), Markus Peck‐Radosavljevic(Klinikum Klagenfurt), Péter Ferenci(Medical University of Vienna), Alfred Gangl(University of Vienna), S. Beinhardt(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Harald Hofer(Klinikum Wels-Grieskirchen), B.A. Payer(Medical University of Vienna), Michael Kundi(Medical University of Vienna), Karoline Rutter(Universität Hamburg), Arnulf Ferlitsch(Medical University of Vienna)
Clinical Gastroenterology and Hepatology
March 11, 2011
10.1016/j.cgh.2011.03.002
Cited by 58

Related Papers

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
|The Lancet|2017|3.1k
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
|Hepatology|2014|2k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k